96 related articles for article (PubMed ID: 21840277)
1. Adherence to hypoglycaemic medication among people with type 2 diabetes in primary care.
White AJ; Kellar I; Prevost AT; Kinmonth AL; Sutton S; Canny M; Griffin SJ
Prim Care Diabetes; 2012 Apr; 6(1):27-33. PubMed ID: 21840277
[TBL] [Abstract][Full Text] [Related]
2. Comparison of Adherence to Glimepiride/Metformin Sustained Release Once-daily Versus Glimepiride/Metformin Immediate Release BID Fixed-combination Therapy Using the Medication Event Monitoring System in Patients With Type 2 Diabetes.
Kim JD; Park CY; Cha BY; Ahn KJ; Kim IJ; Park KS; Lee HW; Min KW; Won JC; Chung MY; Kim JT; Kang JG; Park SW
Clin Ther; 2018 May; 40(5):752-761.e2. PubMed ID: 29729957
[TBL] [Abstract][Full Text] [Related]
3. Adherence to prescribed oral hypoglycaemic medication in a population of patients with Type 2 diabetes: a retrospective cohort study.
Donnan PT; MacDonald TM; Morris AD
Diabet Med; 2002 Apr; 19(4):279-84. PubMed ID: 11942998
[TBL] [Abstract][Full Text] [Related]
4. The management of people with type 2 diabetes with hypoglycaemic agents in primary care: retrospective cohort study.
Calvert MJ; McManus RJ; Freemantle N
Fam Pract; 2007 Jun; 24(3):224-9. PubMed ID: 17488736
[TBL] [Abstract][Full Text] [Related]
5. Multiple outcomes associated with the use of metformin and sulphonylureas in type 2 diabetes: a population-based cohort study in Italy.
Corrao G; Romio SA; Zambon A; Merlino L; Bosi E; Scavini M
Eur J Clin Pharmacol; 2011 Mar; 67(3):289-99. PubMed ID: 21088829
[TBL] [Abstract][Full Text] [Related]
6. Fifty-two-week efficacy and safety of vildagliptin vs. glimepiride in patients with type 2 diabetes mellitus inadequately controlled on metformin monotherapy.
Ferrannini E; Fonseca V; Zinman B; Matthews D; Ahrén B; Byiers S; Shao Q; Dejager S
Diabetes Obes Metab; 2009 Feb; 11(2):157-66. PubMed ID: 19125777
[TBL] [Abstract][Full Text] [Related]
7. Adherence to oral hypoglycaemic agents prior to insulin therapy in Type 2 diabetes.
Evans JM; Donnan PT; Morris AD
Diabet Med; 2002 Aug; 19(8):685-8. PubMed ID: 12147151
[TBL] [Abstract][Full Text] [Related]
8. Wide clinic-level variation in adherence to oral diabetes medications in the VA.
Bryson CL; Au DH; Maciejewski ML; Piette JD; Fihn SD; Jackson GL; Perkins M; Wong ES; Yano EM; Liu CF
J Gen Intern Med; 2013 May; 28(5):698-705. PubMed ID: 23371383
[TBL] [Abstract][Full Text] [Related]
9. Metformin adherence in patients with type 2 diabetes and its association with glycated haemoglobin levels.
Chepulis L; Mayo C; Morison B; Keenan R; Lao C; Paul R; Lawrenson R
J Prim Health Care; 2020 Dec; 12(4):318-326. PubMed ID: 33349319
[TBL] [Abstract][Full Text] [Related]
10. A retrospective cohort study of economic outcomes and adherence to monotherapy with metformin, pioglitazone, or a sulfonylurea among patients with type 2 diabetes mellitus in the United States from 2003 to 2005.
Hansen RA; Farley JF; Droege M; Maciejewski ML
Clin Ther; 2010 Jul; 32(7):1308-19. PubMed ID: 20678679
[TBL] [Abstract][Full Text] [Related]
11. [Identification of factors predicting early evolution of secondary oral hypoglycaemic agent failure and evaluation of clinical standards applied by primary care physicians during qualification to insulin therapy of patients with type 2 diabetes].
Machoy M
Ann Acad Med Stetin; 2004; 50(2):29-39. PubMed ID: 16529163
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the dipeptidyl peptidase-4 inhibitor vildagliptin and the sulphonylurea gliclazide in combination with metformin, in Muslim patients with type 2 diabetes mellitus fasting during Ramadan: results of the VECTOR study.
Hassanein M; Hanif W; Malik W; Kamal A; Geransar P; Lister N; Andrews C; Barnett A
Curr Med Res Opin; 2011 Jul; 27(7):1367-74. PubMed ID: 21568833
[TBL] [Abstract][Full Text] [Related]
13. Treatment adherence with vildagliptin compared to sulphonylurea as add-on to metformin in Muslim patients with type 2 diabetes mellitus fasting during Ramadan.
Hanif W; Malik W; Hassanein M; Kamal A; Geransar P; Andrews C; Azam M; Barnett AH
Curr Med Res Opin; 2013 Jul; 29(7):807-11. PubMed ID: 23659561
[TBL] [Abstract][Full Text] [Related]
14. Adherence to oral antidiabetic agents with pioglitazone and metformin: comparison of fixed-dose combination therapy with monotherapy and loose-dose combination therapy.
Barner JC
Clin Ther; 2011 Sep; 33(9):1281-8. PubMed ID: 21840054
[TBL] [Abstract][Full Text] [Related]
15. Adherence to anti-diabetic drug therapy and self management practices among type-2 diabetics in Nigeria.
Yusuff KB; Obe O; Joseph BY
Pharm World Sci; 2008 Dec; 30(6):876-83. PubMed ID: 18784982
[TBL] [Abstract][Full Text] [Related]
16. Comparative adherence to diabetes drugs: An analysis of electronic health records and claims data.
Flory J; Gerhard T; Stempniewicz N; Keating S; Rowan CG
Diabetes Obes Metab; 2017 Aug; 19(8):1184-1187. PubMed ID: 28266807
[TBL] [Abstract][Full Text] [Related]
17. The association between adherence to oral anti-diabetic drugs and hypoglycaemia in persons with Type 2 diabetes.
Quilliam BJ; Ozbay AB; Sill BE; Kogut SJ
Diabet Med; 2013 Nov; 30(11):1305-13. PubMed ID: 23586474
[TBL] [Abstract][Full Text] [Related]
18. Mortality in type 2 diabetic subjects prescribed metformin and sulphonylurea drugs in combination: cohort study.
Gulliford M; Latinovic R
Diabetes Metab Res Rev; 2004; 20(3):239-45. PubMed ID: 15133756
[TBL] [Abstract][Full Text] [Related]
19. Long-term effects of adding exenatide to a regimen of metformin and/or sulfonylurea in type 2 diabetes: an uncontrolled, open-label trial in Hungary.
Iványi T; Fövényi J; Faludi P; Han J; Macconell L; Wille S; Kiljanski J
Clin Ther; 2012 Jun; 34(6):1301-13. PubMed ID: 22608106
[TBL] [Abstract][Full Text] [Related]
20. Predictors of non-adherence to pharmacotherapy in patients with type 2 diabetes.
Jarab AS; Almrayat R; Alqudah S; Thehairat E; Mukattash TL; Khdour M; Pinto S
Int J Clin Pharm; 2014 Aug; 36(4):725-33. PubMed ID: 24805800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
